0001415889-24-001329.txt : 20240117 0001415889-24-001329.hdr.sgml : 20240117 20240117170034 ACCESSION NUMBER: 0001415889-24-001329 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240115 FILED AS OF DATE: 20240117 DATE AS OF CHANGE: 20240117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Norkunas Matthew CENTRAL INDEX KEY: 0001816836 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39319 FILM NUMBER: 24539165 MAIL ADDRESS: STREET 1: C/O GENERATION BIO CO. STREET 2: 301 BINNEY STREET, SUITE 401 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Generation Bio Co. CENTRAL INDEX KEY: 0001733294 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 814301281 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 857-529-5908 MAIL ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 form4-01172024_050105.xml X0508 4 2024-01-15 0001733294 Generation Bio Co. GBIO 0001816836 Norkunas Matthew C/O GENERATION BIO CO., 301 BINNEY ST CAMBRIDGE MA 02142 false true false false CHIEF FINANCIAL OFFICER 0 Common Stock 2024-01-15 4 M 0 7437 A 47369 D Common Stock 2024-01-15 4 F 0 2577 1.91 D 44792 D Common Stock 2024-01-15 4 M 0 6694 A 51486 D Common Stock 2024-01-15 4 F 0 2320 1.91 D 49166 D Common Stock 2024-01-15 4 M 0 1674 A 50840 D Common Stock 2024-01-15 4 F 0 581 1.91 D 50259 D Restricted Stock Units 2024-01-15 4 M 0 7437 0 D Common Stock 7437 0 D Restricted Stock Units 2024-01-15 4 M 0 6694 0 D Common Stock 6694 20081 D Restricted Stock Units 2024-01-15 4 M 0 1674 0 D Common Stock 1674 6692 D Each restricted stock unit represents the right to receive one share of the company's common stock. On January 21, 2022, the reporting person was granted 59,500 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2022 and the remaining shares vesting in equal quarterly installments thereafter. On January 20, 2023, the reporting person was granted 26,775 restricted stock units. The shares underlying the restricted stock units vest over four years, with 25% of the shares vested on January 15, 2024 and the remaining shares vesting in equal quarterly installments thereafter. On January 20, 2023, the reporting person was granted 13,388 restricted stock units. The shares underlying the restricted stock units vest over two years, with 25% of the shares vested on July 15, 2023 and the remaining shares vesting in equal quarterly installments thereafter. /s/ Benjamin Waters, Attorney-in-Fact 2024-01-17